Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization

Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization
复制标题

靶病灶反应可预测经动脉化疗栓塞治疗的肝细胞癌患者的生存率

DOI:
10.1111/liv.13149
复制
发表时间:
2016-10
影响因子:
6.7
通讯作者:
Shi, Ming
Shi, Ming
中科院分区:
医学2区
文献类型:
--
作者:
Tan, Guo-Sheng;Le, Yong;Wei, Wei;Shi, Ming

文献摘要

参考文献

相似文献

对于TACE后评估为疾病进展(PD)但无分期进展(无SP:仍属于巴塞罗那临床肝癌B)的患者,经动脉化疗栓塞(TACE)的停药规则尚不清楚。我们的目标是评估
The discontinuation rules of transarterial chemoembolization (TACE) for patients who were assessed as progressive disease (PD) but stage progression‐free (SP‐free: still belongs to Barcelona Clinic Liver Cancer B) after TACE are unclear. We aimed to evalu
DOI: 10.1016/j.jhep.2015.01.022
发表时间: 2015-06-01
影响因子: 25.7
作者:
Kim, Beom Kyung;Kim, Seung Up;Han, Kwang-Hyub
通讯作者: Han, Kwang-Hyub
DOI: 10.1158/1078-0432.ccr-12-2721
发表时间: 2013-03-15
影响因子: 11.5
作者:
Kim, Beom Kyung;Kim, Seung Up;Chon, Chae Yoon
通讯作者: Chon, Chae Yoon
DOI: --
发表时间: 2000
期刊: Journal of the National Cancer Institute
影响因子: --
作者:
P. Therasse;S. Arbuck;E. Eisenhauer;J. Wanders;R. Kaplan;L. Rubinstein;J. Verweij;M. V. Van Glabbeke-M.-V.-Van-G
通讯作者: P. Therasse;S. Arbuck;E. Eisenhauer;J. Wanders;R. Kaplan;L. Rubinstein;J. Verweij;M. V. Van Glabbeke-M.-V.-Van-G
DOI: 10.1016/j.ejca.2011.12.021
发表时间: 2012-03-01
影响因子: 8.4
作者:
通讯作者: --
DOI: 10.1159/000440625
发表时间: 2015-01-01
期刊: ONCOLOGY
影响因子: 3.5
作者:
Arizumi, Tadaaki;Ueshima, Kazuomi;Kudo, Masatoshi
通讯作者: Kudo, Masatoshi